Experts Matter. Find Yours.

Aston University joins Birmingham Health Partners alliance

Aston University becomes second university member to join Birmingham Health Partners (BHP) BHP brings together excellence from University of Birmingham and four regional NHS trusts The alliance brings together translational medicine, encompassing health data and academic excellence. Aston University has joined Birmingham Health Partners (BHP), becoming the second university to join the city’s university-NHS partnership. BHP brings together academic, clinical and translational excellence from the University of Birmingham, Aston University and four regional NHS trusts: University Hospitals Birmingham NHS Trust; Birmingham Women’s and Children’s NHS Trust; and more recently Sandwell and West Birmingham NHS Trust, the Royal Orthopaedic NHS Foundation Trust, as well as the regional Academic Health Science Network. BHP is known for its unique ecosystem which enables a full spectrum of translational medicine: encompassing health data, an established local health system, academic excellence and an extensive clinical trials capability – to help bring about answers to complex healthcare issues for the direct benefit of people worldwide. Aston University will be represented at board level by Professor Aleks Subic, Vice-Chancellor and Chief Executive of Aston University. While Professor Anthony Hilton, Pro-Vice-Chancellor & Executive Dean College of the College of Health and Life Sciences will join the executive group of BHP. Professor Hilton said: “We are excited to join BHP because it gives Aston University the chance to develop cross institutional collaborations under one umbrella of BHP. It provides an important forum for engagement with our regional NHS trusts and beneficiaries for both research, education and knowledge exchange. “We are keen to see how the alliance will support the funding of future research, enabling us to share innovation at the boundaries of each institutional expertise. “By having a unified West Midlands approach, we can harness key skills, expertise and our resources to have an impact on health in the region.” Managing Director at BHP, John Williams said: "It gives me great pleasure to welcome Aston University to be part of Birmingham Health Partners. “Alongside our NHS partners we will make use of our shared capabilities as employers, educators and researchers to positively impact the health and economic growth of our region."

Planet 9 Doesn’t Exist, So Why Does It Matter How We Get There? Let Our Expert Explain.

Planet 9 is an oft-discussed hypothetical planet in the outer region of the solar system. A new study involving Florida Tech astrobiologist Manasvi Lingam helps illustrate how we could possibly get there. The study, “Can We Fly to Planet 9?” is from Lingam and researchers Adam Hibberd and Andreas Hein. The team discovered that using current, unmanned transportation methods, it would take 45 to 75 years to get to Planet 9, which is about 42 billion miles away from Earth. By comparison, Pluto, which is the ninth object from the Sun, is roughly three billion miles from Earth. The research and work of Lingam, Hibberd and Hein is also getting a lot of attention from websites like UniverseToday.com. The team also studied near-future transportation methods nuclear thermal propulsion and laser sails. Using nuclear thermal propulsion, it would take approximately 40 years to reach Planet 9. It would take merely six to seven years to reach Planet 9 using laser sail propulsion, which involves using light from lasers to propel the vehicle. In its research, the team used the principles of orbital mechanics, sometimes called spaceflight mechanics. They inputted the complex and nonlinear mathematical equations into a computer, and then solved those equations with some optimization constraints. “What I mean by the latter is that ideally you want to maximize or minimize some quantity as much as possible,” Lingam said. “You might say, ‘Well, I want to minimize the flight time of the spacecraft as much as possible.’ So, what we did is that we put in an optimization constraint. In this case, it happens to be minimizing the time of journey. You solve the mathematical equations for a spacecraft with this condition, and then you end up with the results.” Lingam is inspired by the trendsetting Voyager spacecraft missions of the late 1970s, and one of his goals is to gain additional information about other worlds in our solar system, in addition to Planet 9 Voyager still provides valuable information regarding the outer solar system, though by 2025 it is expected that there may no longer be sufficient power to operate its science instruments. “Any mission to Planet Nine would likewise not just provide valuable information about that hypothetical planet, but it would also yield vital information about Jupiter, because what we do in some of the trajectories is a slingshot or powered flyby around Jupiter,” Lingam said. “It could also provide valuable information about the Sun because we also do a maneuver around the Sun, so you would still be getting lots of interesting data along the journey. And the length of the journey is comparable to that of the functioning time of the Voyager spacecraft today.” If you're a reporter looking to know more - then let us help get you connected to an expert. Manasvi Lingam is an Assistant Professor in the Department of Aerospace, Physics and Space Sciences at the Florida Institute of Technology. He is an author and go-to expert for media when it comes to anything in outer space or out of this world - just recently he was featured in Astronomy.com where he was asked to answer the illusive question - Are we alone?  Manasvi is available to speak with media - simply click on his icon now to arrange an interview today.

Physical models of a patient’s brain help researchers treat neurological disorders and diseases

Brain phantoms are a creative solution for a challenging question: How do you tune an electromagnetic field to a patient without testing on the actual patient? Transcranial magnetic stimulation (TMS) is an application of electromagnetic research with the potential to change the way we treat migraines, depression, obsessive compulsive disorder and even conditions like schizophrenia and Parkinson’s disease. Ravi Hadimani, Ph.D., associate professor of mechanical and nuclear engineering, leads a team of researchers who seek to use TMS to excite or inhibit brain neurons to alter specific brain functions and treat these conditions. This team includes faculty from VCU Health, including Mark Baron, M.D., professor of neurology and Kathryn Holloway, M.D., professor of neurosurgery, as well as outside collaborators like Joan Camprodon, M.D., associate professor of psychiatry at Harvard Medical School. “The brain phantom is a first step,” says Hadimani, “Our ultimate goal is to 3D print a brain fabricated with biomaterial scaffolds and printed neurons that produce a stimulation response similar to neurons in our brain. This model would behave more realistically than current brain phantoms. Our future work involves collaborating with researchers who are able to print lab-grown neurons on biomaterial scaffolds or researchers who directly fabricate artificial neurons onto any scaffold.” Coils used in TMS are responsible for generating the electromagnetic field used in treatment. Individual coils are designed to treat specific diseases, but additional settings like current strength, number of pulses and coil direction are unique to each patient. Refining these settings on the actual patient is not feasible. Computer modeling is also inefficient because creating head models and running simulations from MRI scans of the brain’s complex structure are not spontaneous. Hadimani and his team developed the brain phantom as a novel solution to this problem. In 2018, the first model was created by Hamzah Magsood, one of Hadimani’s Ph.D. students. The brain phantom is a physical model of a patient’s brain designed to specifications obtained from MRI scans. Materials used in brain phantom construction are designed to replicate the electrical conductivity and electromagnetic permeability of different brain sectors. The result is a representation that, when connected to electrodes, provides instantaneous feedback to researchers calibrating TMS coils. Elements of material science, electromagnetics and mechanical prototyping come together to create each brain phantom. The process starts with an MRI, which serves as a map for researchers designing the customized model. This is a careful process. Unlike other areas of the body with clear distinguishing features, like skin, muscle and bone, the brain has subtle differences between its many regions. Researchers must carefully distinguish between these areas to create an accurate brain phantom that will simulate a patient’s skin and skull as well as the brain’s gray and white matter. A composite material of polymer and carbon nanotubes that exhibits electric properties similar to the human brain is the foundation for the brain phantom. Additive manufacturing, more commonly known as 3D printing, is used to create shells for different brain regions based on the patient’s MRI. This shell becomes a mold for the polymer and carbon nanotube solution. Once the brain phantom takes shape within the mold, it is placed within a solution that dissolves the casing, leaving only the brain phantom behind. The conductive parts of the brain phantom are dark because of the carbon nanotubes and non-conductive parts are lighter in color. Electrodes are easily inserted into the brain phantom and provide feedback when an electromagnetic field from the TMS coil is applied. Adjustments to the strength, number of pulses of the field, and coil direction can then be made before applying the treatment to a patient. Having recently received a patent for the brain phantom, Hadimani and Wesley Lohr, a senior biomedical engineering undergraduate, formed Realistic Anatomical Model (RAM) Phantom. The pair have been awarded both the Commonwealth Commercialization Fund Award and the Commonwealth Cyber Initiative Dreams to Reality Incubator Grant. RAM Phantom’s goal is to market brain phantom technology to the growing neuromodulation market, which also includes transcranial direct current stimulation and deep brain stimulation. The company will also aid in the development of advanced brain models that more accurately simulate the properties of the human brain.

How will debates affect upcoming elections? Expert examines Walker-Warnock Senate matchup

Mid-term elections are nearly here and it is debate season for candidates. In Georgia, Sen. Raphael Warnock is set to debate Herschel Walker in Savannah on Oct. 14. This may be the only time the two candidates face off in a debate. But can these events sway a voter one way or another? Augusta University’s Mary-Kate Lizotte is an expert in political and voter behavior and said research shows debates do not have a substantial influence on election outcomes. “Most individuals who watch debates are well informed and therefore very likely to already have a party identification,” Lizotte said. “Sometimes debates do lead to a bump in the polls for a candidate if various news outlets agree that the candidate won. Most of the times, such bumps do not last that long.” But when it comes to a particular issue, she said there is some research that shows if it’s a newer topic, then it can influence public opinion. There has been a lot of attention on this particular debate since Warnock has unsuccessfully tried to engage Walker in other debates. Walker has said he’s not the polished speaker Warnock is and has downplayed the debate during recent speeches. “Walker is probably doing what others have done against a candidate with established oratory skills," adds Lizotte. "George H.W. Bush, George W. Bush, Sarah Palin and Mitt Romney, or their people, worked to lower expectations by conceding that their opponent was a fantastic debater/speaker; then the news media positively covered their debate performance when they performed moderately well or when their opponent does not trounce them.” “This could work in Walker’s favor if they only have one debate. If he gets positive coverage for doing better than expected, then he likely won’t agree to another debate.” With the mid-term elections inching closer and each Senate race crucial to determining the balance of power in Washington, these campaigns will get attention from state and national media. And if you're a reporter looking to cover the race in Georgia, then let us help. Dr. Mary-Kate Lizotte is an expert in political and voter behavior. She is available to talk about the upcoming midterm and gubernatorial elections in Georgia. Click on her name to schedule an interview.

Aston University to launch Aston Centre for Applied Linguistics

The Centre is an interdisciplinary, multilingual group of researchers made up of academic staff and research students It aims to build on Aston University’s longstanding expertise in research into language education, languages, and applied linguistics The hybrid launch event will take place at the University on 14 September Aston University is launching a new research centre within its College of Business and Social Sciences. The Aston Centre for Applied Linguistics (ACAL), formerly known as the Centre for Language Research at Aston (CLaRA), aims to build on Aston University’s longstanding expertise in research into language education, languages, and applied linguistics by promoting interdisciplinary collaboration and establishing national and international networks and partnerships. ACAL is an interdisciplinary, multilingual group of researchers – academic staff and research students – who work in the field of language and language education research. The Centre will officially be launched through a hybrid event at the University on 14 September 2022. There will be talks by Aston University’s Dr Lucia Busso & Dr Marton Petyko, Dr Marcello Giovanelli, Dr Megan Mansworth and Dr Emmanuelle Labeau as well as guest lectures from Professor Zhu Hua (IOE faculty of education and society, UCL) and Terry Lamb (professor of languages and interdisciplinary pedagogy, University of Westminster and Aston University language graduate). The event will conclude with a celebration of the major publications of ACAL members in 2021-22. Dr Emmanuelle Labeau, director of ACAL, said: “Language actually is all around us: we use it to articulate all our human activities. “Languages actually are all around us: over 100 languages are spoken in Birmingham “My recent AHRC-funded project BRUM (Birmingham Research for Upholding Multilingualism) has shown that research in language(s) is needed in local schools, businesses, public services and culture. “ACAL wants to put the ‘applied’ into linguistics to serve the University, the city, region and beyond. Our researchers are a great asset to the University’s ambitions, and we cannot wait informing and helping shape the Aston University 2030 Strategy.”

UConn insect expert David Wagner on the troubling decline of the mayfly

One of the world's oldest flying insects is in trouble. Mayflies are in serious decline and, after 300 million years in existence, their dwindling population should be an alarm bell for all of us. More than just a bug with a short life span flying masterfully near creeks, rivers, and ponds, the mayfly plays a serious role in local ecosystems and the environment at large. A key component in the food chain, the mayfly nymph feeds off of algae, plants, and rotting leaves, cleaning up nature's mess while growing large enough to become a meal itself -- for fish, amphibians, lizards, birds, and even humans. Without mayflies, the ripple effect upwards could mean calamity for the planet. In a recent Washington Post Magazine deep-dive, UConn insect expert David Wagner offered his perspective on the on the plight of the mayfly: I reached out to David Wagner, a biologist and lepidopterist at the University of Connecticut, for context, thinking that perhaps the problems were isolated or overblown. He has studied insects for decades and reviewed numerous scientific studies about them from around the globe. He did not provide much comfort. There’s a growing body of research suggesting that the world is in the midst of its sixth mass extinction, he said. The losses of all kinds of creatures appear to be driven by climate change, habitat degradation, pollution and other ecological stressors. In a paper for the Proceedings of the National Academy of Sciences last year, “Insect Decline in the Anthropocene: Death by a Thousand Cuts,” Wagner and several other scientists delivered a stark warning about the disappearance of insects. The report did not focus on mayflies, but Wagner told me they are among the most vulnerable of the world’s insects because of their need for clean, well-oxygenated water. “Mayflies are reliable ‘canaries in the coal mines’ for freshwater systems,” he explained. “And their future prospects, especially in areas that are drying or warming, are bleak.” September 19 - Washington Post Magazine Dr. David Wagner is an expert in caterpillars, butterflies, moths, and insect conservation, and he's commented extensively on the current decline of insects worldwide. Click his icon to arrange an interview today.

Researchers explore alternate delivery method for potential Alzheimer’s treatment

“Traditionally, the nose has been used as a route for delivery of locally acting drugs,” Laleh Golshahi, Ph.D., explained. “But recently, there has been a great deal of interest in the direct pathway through the olfactory region. That’s the same region where we smell, and that route is a direct pathway to the brain.” Golshahi, associate professor in VCU’s Department of Mechanical and Nuclear Engineering, leads the collaboration. Other members of the group are Worth Longest, Ph.D., the Louis S. and Ruth S. Harris Exceptional Scholar and Professor in the Department of Mechanical and Nuclear Engineering; Michael Hindle, Ph.D., the Peter R. Byron Distinguished Professor in VCU’s Department of Pharmaceutics; and Arya Bazargani, a Ph.D. student in VCU’s Interdisciplinary Center for Pharmaceutical Engineering and Sciences. The project is supported by a $200,000 internal grant from VCU Breakthroughs, a new internal funding mechanism as part of the Optimizing Health thrust of the One VCU Research Strategic Priorities Plan being implemented by the university’s Office of the Vice President for Research and Innovation. Hindle said that studies of nasally administered insulin have shown some promise for reducing the effects of Alzheimer’s. Unfortunately, delivery by injection, the most common way to deliver insulin, is ineffective for Alzheimer’s and other cerebral conditions because of the blood-brain barrier. Bazargani explained that nose-to-brain delivery of pharmaceuticals circumvents the blood-brain barrier, the lining of the blood vessels that surround the brain, guarding the central nervous system against a host of pathogens. “It’s usually a good thing,” he said. “But not when you’re trying to induce therapeutic effects into the brain.” Bazargani explained that insulin molecules are so large that the blood-brain barrier filters out most of the insulin. Hindle pointed out that even though the VCU team is avoiding the blood-brain barrier, insulin delivery still presents a number of challenges. “Insulin is a pretty fragile molecule, you know. It’s stored in the fridge,” Hindle said. “We need to include insulin in some sort of stable formulation — either a powder or a liquid nasal spray. We have to create the right particle or droplet size to get it into the right area of the nose.” Formulation development is only half of a two-pronged challenge, Golshahi said. The second aspect is the creation of a device that can deliver a dose way up to the olfactory region. “The nose is a challenge, because it’s designed as a filter to keep aerosols out of the body,” said Longest, who, along with Golshahi and Hindle, brings expertise in computational fluid dynamics to the team. “And the olfactory region is an especially troubling or difficult region to target, because it’s designed just to let a few molecules of what we inhale deposit.” Chief among the nasal filtering defenses, Golshahi said, is mucociliary clearance. Nasal passages are lined with mucous-coated cilia — moving microscopic projections on cells — sweeping foreign substances out of the air we breathe. The cilia do an excellent job, she said, but their efficiency makes it difficult to achieve a consistent delivery to the olfactory region. Another challenge, she added, lies in the fact that all noses are different. The collaborators are using in vitro and in silico methodologies. For the in vitro work, they have an array of 3D printed nose models, based on computed tomography (CT) scans. Golshahi said they have multiple anatomical casts of human nasal airways to test likely device/formulation combinations for their insulin/Alzheimer’s initiative. “We are going to use three of those nasal casts as our starting point,” she said. “We’ll connect the casts to a breathing simulator, which is basically a machine you can program to add the air going through — sort of bringing them to life.” Golshahi added that data from the casts will inform the in-silico component of the work — computational analysis that is expected to verify or challenge observations from the lab. Hindle said that once the team has developed a satisfactory formulation-device system, they can tackle the next challenge: identifying the dominant pathway from the olfactory region to the brain. “There are a variety of theories out there,” he said. “It could go along the nerve passageway. It could go between the nerve walls and the cells linking them.” “We have all the equipment and all the expertise necessary to be able to develop a formulation, and to put it in a device that leads to the highest amount of delivery to the target region,” Golshahi said. “And we are able to quantify how successful that combination of formulation and device is.”

Tokyo International Conference on African Development

Aston University co-hosted parts of the eighth Tokyo International Conference on African Development (TICAD8). There was a total of six talks hosted by the University, five of which are available to catch up on below. TICAD8 is the eighth event of TICAD, having been initiated by Japan in 1932. The conference brings together international organisations and business representatives from African countries and Japan to promote the digitalisation of African nations to keep pace with other leading economies. Cyber security and data privacy were two of the main topics up for discussion as well as central bank digital currencies (CBDC). CBDC is a government-issued fiat currency, that is, a currency not backed by a commodity such as gold. The use of an ideal CBDC will eliminate over 100,000 armoured cars carrying cash for ATM machines all over the world, reducing CO² emissions. Experts say transitioning to fiat currency requires the highest level of cyber security. The digitalisation of the healthcare sector in Africa Professor Georg Holländer of Oxford University speaks with Aston University visiting professor - and GVE founder - Koji Fusa. The discussion focuses on the benefits of an electronic health record for both an individual and the health care provider but will also relate these benefits to issues of public health and research. The technical challenges of providing the conventional infrastructure to establish health care records will be touched on with a focus placed on data security. Reasons will be pointed out that impede the uptake of electronic health records, especially in low and middle income countries, and possible solutions are presented to overcome this problem. CBDC and private sector digital currency will facilitate the digitalisation of nations of African countries CBDC will require the highest security and privacy protection. Professor Koji Fusa, Cyber Security Innovation Centre, Aston University, CEO of GVE Ltd discusses the benefits of a comprehensive digitalisation of fiat currency. This will become a powerful digital infrastructure which could expand into other areas like healthcare. The cyber security issue pointed by the US NIST in 2016 could be solved by having a different set of systems which could reduce the risks being presented by international hacking groups having quantum computers in the future. The World Bank's support for digitalisation of Africa Takashi Miyahara, the Executive Director of the World Bank Group, presents this talk in his personal capacity. Mr. Miyahara introduces the World Bank’s contribution to date, and Japan’s collaboration with the Bank, for digital development of Africa. Mr. Miyahara worked for the Ministry of Finance of Japan since 1986 before he took the current position in January 2021. Vaccine and climate transition in Africa René Karsenti, senior adviser and honorary president of the International Capital Market Association (ICMA), former board chair of the International Finance Facility for Immunisation (IFFIm), honorary director general of the European Investment Bank (EIB) and member of the Global Advisory Board of GVE Ltd, talks to Aston University's Koji Fusa about vaccine and climate transition in Africa: two major challenges, lessons from innovative ESG financing and future endeavours. Health and vaccine finance, climate transition and sustainable finance have sparked a revolution in thinking about innovative solutions leading to implementing successfully new humanitarian finance such as IFFIm, financing GAVI, the Vaccine Alliance, as well as other new ESG investments to achieve a positive impact. He says: "Needs remain huge in Africa. "We are now at a decisive moment in such ESG investments. We have evolved in a few years from a situation where investors knew - and cared - little about what their investments were supporting, to one where purpose matters more than ever. "But only by recognizing the urgency for action particularly in Africa and the power of ESG investment, collaboration, technology and innovation would get us there." Cyber security, financial integrity and developments Professor George Feiger is the executive dean of the College of Business and Social Sciences at Aston University. He suggests truly secure data transfer has the capability to transform more than medicine and finance in the efficiency sense and also holds out the promise of helping to clean up the even more consequential problem of looting of the state.

Manuka honey could help to clear deadly drug-resistant lung infection – research

• Scientists develop a potential nebulisation treatment using manuka honey to clear a drug resistant lung infection that can be fatal in cystic fibrosis patients • Aston University researchers combined the antibiotic amikacin with manuka honey as a novel treatment for Mycobacterium abscessus • Using the manuka honey combination resulted in an eight-fold reduction in the dosage of the antibiotic A potential new treatment combining natural manuka honey with a widely used drug has been developed by scientists at Aston University to treat a potentially lethal lung infection and greatly reduce side effects of one of the current drugs used for its treatment. The findings, which are published in the journal Microbiology, show that the scientists in the Mycobacterial Research Group in the College of Health and Life Sciences at Aston University were able to combine manuka honey and the drug amikacin in a lab-based nebulisation formulation to treat the harmful bacterial lung infection Mycobacterium abscessus. Manuka honey is long known to have wide ranging medicinal properties, but more recently has been identified for its broad spectrum antimicrobial activity. Now scientists have found that manuka honey has the potential to kill a number of drug resistant bacterial infections such as Mycobacterium abscessus – which usually affects patients with cystic fibrosis (CF) or bronchiectasis. According to the Cystic Fibrosis Trust, CF is a genetic condition affecting around 10,800 people - one in every 2,500 babies born in the UK -and there are more than 100,000 people with the condition worldwide. The NHS defines bronchiectasis as a long-term condition where the airways of the lungs become widened, leading to a build-up of excess mucus that can make the lungs more vulnerable to infection.. In the study, the researchers used samples of the bacteria Mycobacterium abscessus taken from 16 infected CF patients. They then tested the antibiotic amikacin, combined with manuka honey, to discover what dosage was required to kill the bacteria. As part of the study the team used a lab-based lung model and nebuliser - a device that produces a fine spray of liquid often used for inhaling a medicinal drug. By nebulising manuka honey and amikacin together, it was found they could improve bacterial clearance, even when using lower doses of amikacin, which would result in less life-changing side-effects to the patient. In the UK, of the 10,800 people living with CF, Mycobacterium abscessus infects 13% of all patients with the condition. This new approach is advantageous not only because it has the potential to kill off a highly drug resistant infection, but because of the reduced side effects, benefitting quality of life and greatly improving survival chances for infected CF patients. Mycobacterium abscessus is a bacterial pathogen from the same family that causes tuberculosis, but this bug differs by causing serious lung infections in people (particularly children) with pre-existing lung conditions, such as CF and bronchiectasis, as well as causing skin and soft tissue infections. The bacteria is also highly drug resistant. Currently, patients are given a cocktail of antibiotics, consisting of 12 months or more of antimicrobial chemotherapy and often doesn’t result in a cure. The dosage of amikacin usually used on a patient to kill the infection is 16 micrograms per millilitre. But the researchers found that the new combination using manuka honey, required a dosage of just 2 micrograms per millitre of amikacin - resulting in a one eighth reduction in the dosage of the drug. Until now Mycobacterium abscessus has been virtually impossible to eradicate in people with cystic fibrosis. It can also be deadly if the patient requires a lung transplant because they are not eligible for surgery if the infection is present. Commenting on their findings, lead author and PhD researcher Victoria Nolan said: "So far treatment of Mycobacterium abscessus pulmonary infections can be problematic due to its drug resistant nature. The variety of antibiotics required to combat infection result in severe side effects. "However, the use of this potential treatment combining amikacin and manuka honey shows great promise as an improved therapy for these terrible pulmonary infections. “There is a need for better treatment outcomes and in the future we hope that this potential treatment can be tested further.” Dr Jonathan Cox, senior lecturer in microbiology, Aston University said: “By combining a totally natural ingredient such as manuka honey with amikacin, one of the most important yet toxic drugs used for treating Mycobacterium abscessus, we have found a way to potentially kill off these bacteria with eight times less drug than before. This has the potential to significantly reduce amikacin-associated hearing loss and greatly improve the quality of life of so many patients – particularly those with cystic fibrosis. “I am delighted with the outcome of this research because it paves the way for future experiments and we hope that with funding we can move towards clinical trials that could result in a change in strategy for the treatment of this debilitating infection.” Dr Peter Cotgreave, chief executive of the Microbiology Society said: "The Microbiology Society is proud to support the scientific community as it explores innovative solutions to overcome the growing global challenge of antimicrobial resistance. This study demonstrates one of many ways in which microbiologists are pioneering new methods to tackle drug-resistant infections, by incorporating natural products, like manuka honey, into existing therapies." For more information about the School of Biosciences, please visit our website.

Aston University welcomes new Vice-Chancellor and Chief Executive

• Professor Aleks Subic has taken up the role of Vice-Chancellor and Chief Executive, joining Aston University from RMIT in Australia • Professor Subic is a recognised global leader in technology and innovation. Aston University has welcomed Professor Aleks Subic as its new Vice-Chancellor and Chief Executive. He has joined Aston University from RMIT in Australia where he was Deputy Vice-Chancellor of the College of Science, Engineering and Health and Vice President for Digital Innovation. Prior to that, he was Deputy Vice-Chancellor (Research and Enterprise) at Swinburne University of Technology. Professor Subic is a recognised global leader in technology and innovation in higher education, leading on Industry 4.0 strategy and digital transformations across the university sector and with industry and governments both in Australia and internationally. He has received a number of prestigious awards for his work, including the Australian Business Innovation Award and the Victorian Manufacturing Hall of Fame Award. He is a passionate and lifelong advocate for multiculturalism, equality, diversity and inclusion, leading through clear actions and strategic initiatives at enterprise level. These include creating and appointing the first Dean of STEMM Diversity & Inclusion in Australia, establishing Women in STEMM Fellowships and mentoring scheme, Indigenous Research Fellowships, scholarships and internships programs, and creating an innovation precinct with start-up accelerators and industry incubators focused on founders from diverse backgrounds and access. On joining Aston University, Professor Subic said: “I am arriving at a pivotal time in the University’s history, to build on the strong foundations established by its leaders and staff, past and present, and to develop and lead our new bold strategy. Our next stage of development will be ambitious, aiming to achieve our full potential within a rapidly changing world. “I can see huge potential for creating a globally relevant university, a leader in science, technology and enterprise – by transcending academic disciplines, applying the knowledge we create and driving innovation, to improve the lives and livelihoods of those with whom we work. “Building on our collective expertise, experience and professional networks, I look forward to supporting our students, industries and communities in Birmingham and the West Midlands region, as well as our strategic partners nationally and internationally.” Professor Subic is married to Tatjana, and they have three children: Sandra, Katarina and Stefan.